Prediction of peri-procedural cerebrovascular accidents in patients with severe peripheral artery disease undergoing transcatheter aortic valve replacement
Vascular Pharmacology · 2026
DOI: 10.1016/j.vph.2026.107674 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Vascular Pharmacology, 2026. Verfasst von Giulia Costa und 57 weiteren Autor:innen. Beteiligte Einrichtung: Cardiothoracic and Vascular Department, Pisa University Hospital, Pisa, Italy. Hauptthemen laut MEDLINE: Peripheral Arterial Disease, Transcatheter Aortic Valve Replacement, Aortic Valve Stenosis, Catheterization, Peripheral. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVES: Several models have been evaluated for the prediction of transcatheter aortic valve replacement (TAVR)-related cerebrovascular accidents (CVA). The HOSTILE registry recently investigated TAVR outcomes in patients with severe peripheral artery disease (PAD), assessed using a multi-parameter score (HOSTILE score). Among patients treated with transfemoral access (TFA), higher HOSTILE score was associated with higher rates of CVA. We sought to assess the efficacy of different modalities of risk estimation for TAVR-related CVA prediction in a population with severe PAD. METHODS: The predictive ability of the risk assessment modalities was compared using the area under the receiving-operator characteristic (ROC) curve and Harrell's C-statistic. The pre-defined outcome was any CVA occurring within 30 days after TAVR. RESULTS: The study population consisted of 1707 patients, 518 (30.3%) treated via TFA and 1189 treated via transthoracic and trans-axillary routes. The CHA2DS2-VASc and the HOSTILE score showed fair performance only in the TFA cohort (AUC 0.68, 95% CI 0.53-0.83, and 0.68, 95% CI 0.55-0.81, respectively); values of CHA2DS2-VASc >5 and HOSTILE >6 exhibited the best discriminatory ability. The highest risk group (CHA2DS2-VASc >5 and HOSTILE >6) showed a five-fold higher incidence of CVA as compared to the other groups (incidence 6.7%; HR: 5.38, CI95%: 1.80-16.01; p = 0.003). CONCLUSIONS: In a population of patients with severe PAD treated with TAVR via TFA, the integration of a clinical score (CHA2DS2-VASc score) with a purely anatomical one (HOSTILE score) increased the discriminative ability towards 30-day CVA. Further analyses are needed in order to prospectively evaluate this strategy in different cohorts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiothoracic and Vascular Department, Pisa University Hospital, Pisa, Italy.
- Cardiology Unit, Cardiac Thoracic and Vascular Department, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Italy; Cardiac Thoracic and Vascular Department, Università di Bologna, Italy.
- Kerckhoff Heart Center, Bad Nauheim, Germany.
- UOSA Cardiologia Interventistica Azienda Ospedaliera Universitaria Senese, Siena, Italy.
- The Heart Center, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
- U.O.C. di Interventistica Cardiologica e Diagnostica Invasiva, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
Zitieren
APA
Costa, G., Mazzola, M., Sticchi, A., Palmerini, T., Saia, F., Bruno, A. G., Kim, W. K., Renker, M., Iadanza, A., Fineschi, M., Vanhaverbeke, M., De Backer, O., Romagnoli, E., Burzotta, F., Trani, C., Adrichem, R., Van Mieghem, N. M., Tomii, D., Pilgrim, T., …, & De Carlo, M. (2026). Prediction of peri-procedural cerebrovascular accidents in patients with severe peripheral artery disease undergoing transcatheter aortic valve replacement. Vascular Pharmacology. https://doi.org/10.1016/j.vph.2026.107674
Vancouver
Costa G, Mazzola M, Sticchi A, Palmerini T, Saia F, Bruno AG, et al. Prediction of peri-procedural cerebrovascular accidents in patients with severe peripheral artery disease undergoing transcatheter aortic valve replacement. Vascular Pharmacology. 2026. doi:10.1016/j.vph.2026.107674
BibTeX
@article{Costa2026,
author = {Costa, Giulia and Mazzola, Matteo and Sticchi, Alessandro and Palmerini, Tullio and Saia, Francesco and Bruno, Antonio Giulio and Kim, Won-Keun and Renker, Matthias and Iadanza, Alessandro and Fineschi, Massimo and Vanhaverbeke, Maarten and De Backer, Ole and Romagnoli, Enrico and Burzotta, Francesco and Trani, Carlo and Adrichem, Rik and Van Mieghem, Nicolas M and Tomii, Daijiro and Pilgrim, Thomas and Aranzulla, Tiziana Claudia and Musumeci, Giuseppe and Adam, Matti and Meertens, Max M and Alvarez-Covarrubias, Hector Alfonso and Joner, Michael and Meucci, Francesco and Di Mario, Carlo and Loretz, Lucca and Toggweiler, Stefan and Testa, Luca and Bedogni, Francesco and Berti, Sergio and Ancona, Marco B and Montorfano, Matteo and Gmeiner, Jonas and Braun, Daniel and Nerla, Roberto and Castriota, Fausto and Barbanti, Marco and Tamburino, Corrado and Leone, Pier Pasquale and Reimers, Bernhard and Stefanini, Giulio and Sudo, Mitsumasa and Nickenig, Georg and Piva, Tommaso and Scotti, Andrea and Latib, Azeem and Vercellino, Matteo and Porto, Italo and Frumento, Paolo and Codner, Pablo and Kornowski, Ran and Bartorelli, Antonio L and Tarantini, Giuseppe and Fraccaro, Chiara and Abdel-Wahab, Mohamed and De Carlo, Marco},
title = {Prediction of peri-procedural cerebrovascular accidents in patients with severe peripheral artery disease undergoing transcatheter aortic valve replacement},
journal = {Vascular Pharmacology},
year = {2026},
doi = {10.1016/j.vph.2026.107674}
}
EUVIMED